InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by DILLY STEPHEN GEORGE. Director active across 4 companies, notably Sierra Oncology, Inc.. Aggregated, 11 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €241k. Activity tracked since 19 May 2021. The latest transaction was filed on 5 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
88,750 shares0Common StockSEC:0000905148-25-000438:0
143,425 shares0Common StockSEC:0000905148-24-000029:0
58,479 shares@ US$1.7263100.0% of flowCommon StockSEC:0000905148-23-000900:0
Ideal exit: 4 Jun 2024 (T+270)
289,000 shares0Common StockSEC:0001567619-23-004772:0
112,500 shares0Common StockSEC:0001567619-23-003441:0
5,000 shares@ US$55.0078.2% of flowCommon StockSEC:0001209191-22-040252:0
11,273 shares0Common StockSEC:0001567619-22-012978:0
4,796 shares0Common StockSEC:0001567619-21-012328
4,796 shares0Common StockSEC:0001567619-21-012328:0
5,000 shares@ US$17.83100.0% of flowCommon StockSEC:0001209191-21-034601
Ideal exit: 13 Feb 2022 (T+270)
5,000 shares@ US$17.8321.8% of flowCommon StockSEC:0001209191-21-034601:0
Ideal exit: 13 Feb 2022 (T+270)
11 of 11 declarations
About DILLY STEPHEN GEORGE
Dilly Stephen George is a director at Sierra Oncology, Inc. and CODEXIS, INC.
